Finance

Lists
Why is MTNB up 9.09%?
Dive Deeper
MTNB:NYSEAMERICAN
Matinas BioPharma Holdings Inc
$2.64
+9.09%
(+0.22) 1D
$2.87
+8.71% (+0.23)
After hours
Closed: Oct 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MTNB...
Open
$2.53
High
$2.75
Low
$2.42
Mkt. cap
2.59M
Avg. vol.
771.49K
Volume
295.50K
52-wk high
$29.55
52-wk low
$2.26
EPS
-$16.39
Beta
2.25
Shares outstanding
980.00K
No. of employees
2
Open
$2.53
High
$2.75
Low
$2.42
Mkt. cap
2.59M
Avg. vol.
771.49K
Volume
295.50K
52-wk high
$29.55
52-wk low
$2.26
EPS
-$16.39
Beta
2.25
Shares outstanding
980.00K
No. of employees
2
News stories
From web sources and news partners
About Matinas BioPharma Holdings Inc
CEO-
Employees2
Founded2013
HeadquartersBedminster, New Jersey, United States
SectorBiotechnology
Websitematinasbiopharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.58M
1.60M
1.94M
1.56M
Operating expense
1.58M
1.60M
1.94M
1.56M
Total operating expenses
1.58M
1.60M
1.94M
1.56M
Operating income
-1.58M
-1.60M
-1.94M
-1.56M
Other non operating income
45.00K
-238.00K
15.00K
-1.00K
EBT including unusual items
-1.53M
-1.91M
-1.92M
-1.33M
EBT excluding unusual items
-1.53M
-1.84M
-1.92M
-1.56M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.53M
-1.91M
-1.92M
-1.33M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-1.00K
-
-
Net interest expenses
-
-1.00K
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.58M
-1.60M
-1.93M
-1.55M
Gain or loss from assets sale
-
73.00K
-
138.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps